Satoshi Tamaru

448 total citations
46 papers, 255 citations indexed

About

Satoshi Tamaru is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Satoshi Tamaru has authored 46 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Satoshi Tamaru's work include Lymphoma Diagnosis and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Satoshi Tamaru is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Satoshi Tamaru collaborates with scholars based in Japan, Germany and United States. Satoshi Tamaru's co-authors include Hiroshi Shiku, Naoyuki Katayama, Yuki Nishimura, Masakatsu Nishikawa, Kana Miyazaki, Motoko Yamaguchi, Toru Ogura, J. Yamada, Tatsuhiko Fujiwara and Tohru Kobayashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Satoshi Tamaru

36 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Tamaru Japan 9 95 61 59 42 41 46 255
K Jenner United Kingdom 5 86 0.9× 56 0.9× 49 0.8× 30 0.7× 49 1.2× 7 430
Izabella Czajka-Oraniec Poland 8 29 0.3× 45 0.7× 130 2.2× 8 0.2× 7 0.2× 17 352
Usha Sriram India 8 38 0.4× 55 0.9× 170 2.9× 14 0.3× 12 0.3× 13 435
Ji Young Joung South Korea 15 37 0.4× 126 2.1× 29 0.5× 9 0.2× 15 0.4× 23 428
Stephen Shafizadeh United States 11 105 1.1× 284 4.7× 14 0.2× 35 0.8× 8 0.2× 16 431
Elizabeth A. Swallow United States 12 54 0.6× 31 0.5× 69 1.2× 6 0.1× 20 0.5× 32 325
D E Carey United States 6 45 0.5× 61 1.0× 51 0.9× 38 0.9× 26 0.6× 9 334
Guangheng Luo China 11 23 0.2× 69 1.1× 26 0.4× 12 0.3× 9 0.2× 47 350
Valeria Grancini Italy 10 25 0.3× 81 1.3× 40 0.7× 8 0.2× 26 0.6× 28 423
Rajarajan Ramamoorthy United Kingdom 8 52 0.5× 144 2.4× 181 3.1× 53 1.3× 23 0.6× 9 375

Countries citing papers authored by Satoshi Tamaru

Since Specialization
Citations

This map shows the geographic impact of Satoshi Tamaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Tamaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Tamaru more than expected).

Fields of papers citing papers by Satoshi Tamaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Tamaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Tamaru. The network helps show where Satoshi Tamaru may publish in the future.

Co-authorship network of co-authors of Satoshi Tamaru

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Tamaru. A scholar is included among the top collaborators of Satoshi Tamaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Tamaru. Satoshi Tamaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamagata, K, et al.. (2025). Androgens modulate endometrial function. Medical Molecular Morphology. 58(2). 93–99.
3.
Shiromizu, Takashi, et al.. (2024). Lansoprazole Ameliorates Isoniazid-Induced Liver Injury. Pharmaceuticals. 17(1). 82–82.
4.
Ogihara, Yoshito, Norikazu Yamada, Daisuke Izumi, et al.. (2024). Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial. Research and Practice in Thrombosis and Haemostasis. 8(5). 102515–102515. 1 indexed citations
5.
Nakamura, Mashio, Satoshi Tamaru, Atsushi Hirayama, et al.. (2023). Efficacy and Safety of Warfarin for the Treatment of Venous Thromboembolism ― A Multicenter Prospective Observational Cohort Study in Japan (AKAFUJI Study) ―. Circulation Journal. 88(3). 359–368. 2 indexed citations
6.
Hamada, Yasuhiko, Kyosuke Tanaka, Noriyuki Horiki, et al.. (2023). Negative effect of prolonged cecal intubation time on adenoma detection in female patients. JGH Open. 7(2). 128–134. 1 indexed citations
7.
Hamada, Yasuhiko, Kyosuke Tanaka, Katsumi Mukai, et al.. (2023). Efficacy of Endoscopic Resection for Rectal Neuroendocrine Tumors Smaller than 15 mm. Digestive Diseases and Sciences. 68(7). 3148–3157. 5 indexed citations
9.
Ikemura, Kenji, Toshiro Mizuno, Kazuhiko Takeuchi, et al.. (2022). Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity. Frontiers in Pharmacology. 13. 896760–896760. 8 indexed citations
10.
Yamada, Reiko, Shuji Isaji, Takehiro Fujii, et al.. (2021). Improving the Prognosis of Pancreatic Cancer Through Early Detection: Protocol for a Prospective Observational Study. JMIR Research Protocols. 10(10). e26898–e26898. 3 indexed citations
11.
Tsunoda, Akira, Mikiya Ishihara, Kanako Saito, et al.. (2021). P1-9 Retrospective analysis of the efficacy and safety of FOLFOX in patients with esophageal cancer. Annals of Oncology. 32. S329–S329.
12.
Maki, Shintaro, Hiroaki Tanaka, Makoto Tsuji, et al.. (2019). Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial. Journal of Clinical Medicine. 8(6). 856–856. 27 indexed citations
13.
Umekawa, Takashi, Shintaro Maki, Michiko Kubo, et al.. (2018). TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial. BMJ Open. 8(10). e020948–e020948. 8 indexed citations
14.
Ishihara, Mikiya, Satoshi Tamaru, Yoshiki Yamashita, et al.. (2015). Two cases of clinical tumor lysis syndrome following lapatinib in HER2 positive breast cancer. Annals of Oncology. 26. vii143–vii143. 1 indexed citations
15.
Tanaka, Shiro, Kazuhiro Yanagihara, Satoshi Tamaru, et al.. (2011). Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer. International Journal of Clinical Oncology. 18(1). 17–25. 3 indexed citations
16.
Nishikawa, Masakatsu & Satoshi Tamaru. (2009). 1. Molecular Mechanisms and Characteristics of Antiplatelet Drugs. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 40(6). 253–260. 1 indexed citations
17.
Miyazaki, Kana, Motoko Yamaguchi, Hiroshi Imai, et al.. (2008). Gene expression profiling of peripheral T-cell lymphoma including γδ T-cell lymphoma. Blood. 113(5). 1071–1074. 37 indexed citations
18.
Tamaru, Satoshi, Kenji Kitajima, Tohru Nakano, et al.. (2007). Calyculin A retraction of mature megakaryocytes proplatelets from embryonic stem cells. Biochemical and Biophysical Research Communications. 366(3). 763–768. 2 indexed citations
19.
Tamaru, Satoshi, et al.. (2005). Rho-kinase induces association of adducin with the cytoskeleton in platelet activation. Biochemical and Biophysical Research Communications. 332(2). 347–351. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026